Is there a prostate‐specific antigen upper limit for radical prostatectomy?Paolo Gontero, Steven Joniau, Martin Spahn et al.|British Journal of Urology|2011Cited by 25
Quality of life evaluation by the EORTC QLQ-C30 questionnaire in patients treated with hormonal treatment in Italy. A QuABIOS group study.Domenico Prezioso, Filiberto Zattoni, Ettore Mearini et al.|PubMed|2007Cited by 5
363 STRATIFICATION OF HIGH-RISK PROSTATE CANCER INTO PROGNOSTIC CATEGORIES; A EUROPEAN MULTI-INSTITUTIONAL STUDYSteven Joniau, Martin Spahn, Paolo Gontero et al.|The Journal of Urology|2012Cited by 4
469 ONCOLOGICAL OUTCOMES AFTER RADICAL PROSTATECTOMY IN LOCALLY ADVANCED PROSTATE CANCER: A MULTI-CENTER EXPERIENCESteven Joniau, Paolo Gontero, Chao‐Yu Hsu et al.|The Journal of Urology|2011Cited by 1
998 HIGH-RISK PROSTATE CANCER PRESENTING WITH BIOPSY GLEASON SCORE 8, 9 OR 10: DOWNGRADING AND CANCER-SPECIFIC SURVIVALSteven Joniau, Paolo Gontero, Martin Spahn et al.|The Journal of Urology|2012Cited by 0